NYSE - Delayed Quote • USD Doximity, Inc. (DOCS) Follow Add holdings 52.09 +0.15 +(0.29%) At close: May 30 at 4:00:02 PM EDT 52.54 +0.45 +(0.86%) Pre-Market: 6:33:32 AM EDT All News Press Releases SEC Filings The Strong Earnings Posted By Doximity (NYSE:DOCS) Are A Good Indication Of The Strength Of The Business Doximity, Inc.'s ( NYSE:DOCS ) earnings announcement last week was disappointing for investors, despite the decent... 3 High-Flying Stocks to Research Further Expensive stocks often command premium valuations because the market thinks their business models are exceptional. However, the downside is that high expectations are already baked into their prices, leaving little room for error if they stumble even slightly. Jim Cramer on Doximity (DOCS): “I Cannot Get Behind That” We recently published a list of Jim Cramer Discussed These 9 Stocks Recently. In this article, we are going to take a look at where Doximity, Inc. (NYSE:DOCS) stands against other stocks that Jim Cramer discussed recently. Noting that the stock tanked after earnings on weak guidance, a caller asked for Cramer’s opinion of Doximity, […] Doximity to Present at the William Blair 45th Annual Growth Stock Conference SAN FRANCISCO, May 21, 2025--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced that Jeff Tangney, co-founder and CEO, will present at the William Blair 45th Annual Growth Stock Conference on Tuesday, June 3, 2025 at 4:40 p.m. Central Time. Doximity: Strong Growth but What's Next? Digital medical platform leader Doximity reported better-than-expected results on the top and bottom lines. Free cash flow grew by more than 50% year over year, and margins are stellar. At first glance, Doximity's earnings report looked rather strong. Doximity Full Year 2025 Earnings: EPS Beats Expectations Doximity ( NYSE:DOCS ) Full Year 2025 Results Key Financial Results Revenue: US$570.4m (up 20% from FY 2024). Net... These Stocks Moved the Most Today: UnitedHealth, Applied Materials, Novo Nordisk, Super Micro, Coinbase, Doximity, Quantum Computing, and More UnitedHealth stock is rising after declining for eight consecutive sessions, Applied Materials issues a disappointing revenue outlook, and Doximity falls sharply after its revenue forecast misses analysts’ estimates. Why Doximity (DOCS) Shares Are Trading Lower Today Shares of healthcare professional network Doximity (NYSE:DOCS) fell 11.7% in the afternoon session after the company reported weak first quarter 2025 results: its revenue guidance for next year fell short of Wall Street's estimates and suggested a significant slowdown in demand. Notably, top-line growth decelerated significantly, up 17% (versus 25% growth in the previous quarter). Why Doximity Stock Is Plummeting Today Leading digital healthcare platform Doximity rocketed past analysts' expectations, but offered up disappointing guidance. Shares of the leading digital platform for U.S. medical professionals, Doximity (NYSE: DOCS), were down 14% as of noon ET Friday, according to data provided by S&P Global Market Intelligence. Doximity wrapped up its fiscal 2025 on Friday, delivering revenue and free cash flow (FCF) growth of 20% and 50%, respectively, during the year. Doximity Stock Plummets Even as Earnings Beat Expectations. What’s Behind the Drop. For the fiscal fourth quarter, adjusted earnings were 38 cents a share on revenue of $138.3 million, comfortably above expectations. Doximity Stock Plunges Despite Q4 Earnings & Sales Beat, Margins Up DOCS reports robust growth in unique active users and sales of workflow tools, driving the top and bottom lines. First-quarter fiscal 2026 sales outlook below estimates. Doximity Inc (DOCS) Q4 2025 Earnings Call Highlights: Surpassing Expectations with Strong ... Doximity Inc (DOCS) reports impressive Q4 results, exceeding revenue guidance and showcasing robust growth, while navigating macroeconomic challenges with strategic AI advancements. Doximity Stock Drops 20% After Outlook Disappoints Shares of Doximity plummeted late Thursday after the telehealth software company dished out a disappointing outlook. Doximity (DOCS) Surpasses Q4 Earnings and Revenue Estimates Doximity (DOCS) delivered earnings and revenue surprises of 40.74% and 3.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock? Doximity: Fiscal Q4 Earnings Snapshot The San Francisco-based company said it had profit of 31 cents per share. Earnings, adjusted for one-time gains and costs, came to 38 cents per share. The results topped Wall Street expectations. Doximity (NYSE:DOCS) Posts Better-Than-Expected Sales In Q1 But Stock Drops 18.2% Healthcare professional network Doximity (NYSE:DOCS) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 17.1% year on year to $138.3 million. On the other hand, next quarter’s revenue guidance of $139.5 million was less impressive, coming in 2.4% below analysts’ estimates. Its non-GAAP profit of $0.38 per share was 39.3% above analysts’ consensus estimates. Doximity Announces Fourth Quarter and Fiscal Year 2025 Financial Results SAN FRANCISCO, May 15, 2025--Doximity, Inc. (NYSE: DOCS), the leading digital platform for U.S. medical professionals, today announced results of its fiscal 2025 fourth quarter and fiscal year ended March 31, 2025. Doximity (DOCS) Reports Earnings Tomorrow: What To Expect Healthcare professional network Doximity (NYSE:DOCS) will be reporting results tomorrow after the bell. Here’s what to look for. Biodesix, Inc. (BDSX) Reports Q1 Loss, Misses Revenue Estimates Biodesix (BDSX) delivered earnings and revenue surprises of 0% and 7.19%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock? Doximity Q4 Earnings Likely to Reflect Strong Product Momentum Doximity's Q4 performance likely witnessed strong product-driven gains from new modules and integrated programs, though early revenue pull-forward might have tempered sequential growth. Performance Overview Trailing total returns as of 5/30/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) Return DOCS S&P 500 (^GSPC) YTD -2.43% +0.51% 1-Year +87.71% +12.92% 3-Year +47.19% +42.17%